Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Shengbaikeli vs Diyushengbai Tablets for leukopenia and cancer-related fatigue
ChiCTR2600123973Phase 4Not yet recruiting
- Sponsor
- First People's Hospital of Lianyungang City
- Start
- May 2026
- Countries
- 1
01
Overview
Phase 4, randomised trial of shengbaikeli in leukopenia and cancer (2 arms), sponsored by First People's Hospital of Lianyungang City. Primary endpoint: Blood routine (white blood cell and neutrophil counts). Planned start May 2026; status: not yet recruiting.
02
Drugs
shengbaikeli
03
Conditions
leukopeniacancer
Beyond the preview
Go deeper on ChiCTR2600123973.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600123973.